Chiron Real Estate Inc. (XRN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on February 25, 2026, by Chiron Real Estate Inc. (formerly Global Medical REIT Inc.). The report covers corporate governance changes effective February 23, 2026, and references the Company's financial results for the three months and full year ended December 31, 2025.
Key Financial Metrics
The filing references an Earnings Release and Supplemental for the period ended December 31, 2025, but does not contain specific numerical data within the text of this 8-K. Specific values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document and must be sourced from the attached Exhibits 99.1 and 99.2.
Material Changes
- Corporate Name Change: Effective February 23, 2026, the Company changed its name from Global Medical REIT Inc. to Chiron Real Estate Inc. The Operating Partnership was similarly renamed from Global Medical REIT L.P. to Chiron Real Estate LP.
- Trading Symbols: NYSE trading symbols were updated to reflect the new name:
- Common Stock: Changed from "GMRE" to "XRN".
- Series A Preferred Stock: Changed from "GMRE PrA" to "XRN PrA".
- Series B Preferred Stock: Changed from "GMRE PrB" to "XRN PrB".
- Corporate Governance: The Company filed Articles of Amendment to its charter and adopted Fifth Amended and Restated Bylaws to effectuate the name change.
- Digital Presence: A new corporate website (www.chironre.com) was launched on February 23, 2026.
Guidance, Outlook, and Risks
The filing includes a Regulation FD disclosure regarding an investor presentation posted on February 25, 2026. The text of this 8-K does not provide specific forward-looking guidance, management commentary on future performance, or a detailed discussion of risks and contingencies. These details are contained within the referenced Earnings Release and Investor Presentation (Exhibits 99.1 and 99.3).
Investor Verification Checklist
- Verify the specific financial results for Q4 and Full Year 2025 by reviewing Exhibit 99.1 (Earnings Release) and Exhibit 99.2 (Earnings Supplement).
- Confirm the updated trading symbols (XRN, XRN PrA, XRN PrB) on brokerage platforms to ensure accurate trading.
- Review the new corporate website (www.chironre.com) for updated investor relations materials and press releases.
- Examine the Articles of Amendment (Exhibit 3.1) and Fifth Amended and Restated Bylaws (Exhibit 3.2) for any additional governance changes beyond the name change.